Skip to: Curated Story Group 1
lifesciencesreview

Advertise

with us

    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Topics
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Business Services
    Business Services
    Business Services
    Business Services
    Business Services
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Pharmacy Management
    Regulatory Services
  • CXO Insights
  • Vendor Viewpoint
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • CXO Awards
OCTOBER 2024LIFE SCIENCES REVIEW 19CXO INSIGHTSAlan Dow, Director, Neurosciences Clinical Service Line & Neuro-Oncology, Barnes-Jewish HospitalNAVIGATING THE FUTURE OF NEURODEGENERATIVEDISEASE SERVICESWhat are your key Roles and Responsibilities at Barnes-Jewish Hospital?As the service line director for Neuroscience at Barnes-Jewish Hospital, part of the BJC Health System, I am responsible for strategic planning, new program/business development, performance improvement, finance and the implementation of multi-disciplinary strategies across the care continuum. Working collaboratively with our Washington University Physicians partners and hospital clinical leaders, I identify and establish long- and short-term strategies relating to Neurology, Neurosurgery, Neuro-Oncology, and Neuro/Ortho Spine services across all hospital-based sites of care to expand treatment and service offerings to the patients we serve.What are the major areas of growth opportunity you see in the neurodegenerative disease space? It is an exciting time in the field of neurodegenerative diseases, with new therapies arriving on the market faster than we have ever seen before. Over the past few years, we have seen the first FDA-approved treatments for Alzheimer's that have been shown to slow disease progression, and I had the privilege of leading our
< Page 9 | Page 11 >